Vancouver AIDS researcher in D.C. endorsing prevention plan

Vancouver AIDS researchers will be pushing their HIV treatment-as-prevention plan at the massive international AIDS conference, starting today in Washington D.C.

The man behind the pioneering effort says it has to apply to rich and poor countries.

“It has been a long-term concern for us that anything that we do here in BC and North America or in the rich parts of the world, we find the means to translate it in a way that can be readily applicable to other jurisdictions in the world,” says Dr. Julio Montaner, the head of the BC Centre for Excellence in HIV/AIDS.

He says they’ve been able to do that in some areas.

“Latin America, China – China has been incredible. They’ve embraced our treatment-as-prevention strategy full heartily,” Montaner explains. “We’re doing it in Africa, so this is happening.”

Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below